Endocrine-Therapy-Resistant ESR1 Variants Revealed by Genomic Characterization of Breast-Cancer-Derived Xenografts-Reference-Cited by-同舟云学术

Endocrine-Therapy-Resistant ESR1 Variants Revealed by Genomic Characterization of Breast-Cancer-Derived Xenografts

Published:2013-09 Issue:6 Volume:4 Page:1116-1130
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Li Shunqiang,Shen Dong,Shao Jieya,Crowder Robert,Liu Wenbin,Prat Aleix,He Xiaping,Liu Shuying,Hoog Jeremy,Lu Charles,Ding Li,Griffith Obi L.,Miller Christopher,Larson Dave,Fulton Robert S.,Harrison Michelle,Mooney Tom,McMichael Joshua F.,Luo Jingqin,Tao Yu,Goncalves Rodrigo,Schlosberg Christopher,Hiken Jeffrey F.,Saied Laila,Sanchez Cesar,Giuntoli Therese,Bumb Caroline,Cooper Crystal,Kitchens Robert T.,Lin Austin,Phommaly Chanpheng,Davies Sherri R.,Zhang Jin,Kavuri Megha Shyam,McEachern Donna,Dong Yi Yu,Ma Cynthia,Pluard Timothy,Naughton Michael,Bose Ron,Suresh Rama,McDowell Reida,Michel Loren,Aft Rebecca,Gillanders William,DeSchryver Katherine,Wilson Richard K.,Wang Shaomeng,Mills Gordon B.,Gonzalez-Angulo Ana,Edwards John R.,Maher Christopher,Perou Charles M.,Mardis Elaine R.,Ellis Matthew J.

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference54 articles.

1. Smad4 loss in mice causes spontaneous head and neck cancer with increased genomic instability and inflammation;Bornstein;J. Clin. Invest.,2009

2. Comprehensive molecular portraits of human breast tumours;Nature,2012

3. Comprehensive genomic characterization of squamous cell lung cancers;Nature,2012

4. In situ analyses of genome instability in breast cancer;Chin;Nat. Genet.,2004

5. Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes;DeRose;Nat. Med.,2011

Cited by 537 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pyrimidine–triazole‐tethered tert‐butyl‐piperazine‐carboxylate suppresses breast cancer by targeting estrogen receptor signaling and β‐catenin activation;IUBMB Life;2024-09-14

2. Estrogen-Receptor Loss and ESR1 Mutation in Estrogen-Receptor-Positive Metastatic Breast Cancer and the Effect on Overall Survival;Cancers;2024-08-30

3. ESR1 Fusions Invoke Breast Cancer Subtype-Dependent Enrichment of Ligand-Independent Oncogenic Signatures and Phenotypes;Endocrinology;2024-08-27

4. An ultra-sensitive and rapid immunosensor for the onsite detection of circulating tumor DNA in breast cancer;Frontiers in Bioengineering and Biotechnology;2024-07-12

5. A Pan-Cancer Patient-Derived Xenograft Histology Image Repository with Genomic and Pathologic Annotations Enables Deep Learning Analysis;Cancer Research;2024-07-02